I understand what you are saying, but in right now, what we do have that does have value is GNBT shares. What we know will have value leading up to the NGIO listing is GNBT shares and what we do know will have value after the listing, GNBT shares. There is no debate on that point.

We can all agree or disagree what should be done or not done with the NGIO shares, if they were a gift, compensation, or whatever. It is frustrating when you have shares in a company and you are now told you have to wait to see what happens with them. I get that and I am impacted quite a bit on it.

But, what I am impacted the most on and it is undeniable to me is my GNBT shares as they currently have a value around .28 a share. I am in the negative on that. I am not in the negative on NGIO shares right now. What I want to see is my GNBT share PPS to go up and I want to know that the listing of NGIO will or should have a positive impact on it, along with a revenue stream from Excellegen and from Florida and Arizona. Right now, I am wondering why Generex is silent on those as they affect all shareholders now financially. NGIO will impact shareholders once the dividend shares are truly worth anything. GNBT shares are worth something now which is not much.